Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hyperhomocysteinemia and the MTHFR C677T mutation in Budd-Chiari syndrome.

American journal of hematology - 1 Sept 2002

Li Xiao-Mei, Wei Ying-Fei, Hao Hong-Ling, Hao Yu-Bin, He Li-Shan, Li Jing-Dong, Mei Bing, Wang Su-Yun, Wang Chao, Wang Jun-Xiang, Zhu Jun-Zhen, Liang Jin-Quan

Abstract excerpt

Hyperhomocysteinemia (HH) is a factor that predisposes individuals to thrombosis, and the C677T mutation in the 5,10-methylenetetrahydrofolate reductase (MTHFR) is known to give increased plasma homocysteine. However, little is known about their roles in Budd-Chiari syndrome (BCS). This study evaluated the roles of HH and the MTHFR C677T mutation in patients with BCS. We compared 41 BCS patients with 80 sex- and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Budd-Chiari Syndrome
Share to Hyperhomocysteinemia

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Methylenetetrahydrofolate Reductase (NADPH2)

Share to Odds Ratio

Share to Oxidoreductases Acting on CH-NH Group Donors

Share to Point Mutation

Share to Thrombophilia

Source

Identifiers

PMID: 12221667
DOI: 10.1002/ajh.10149

Genes

MTHFR

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hyperhomocysteinemia and the MTHFR C677T mutation in Budd-Chiari syndrome.PMID 12221667Read ↗

Hyperhomocysteinemia and the methylene tetrahydrofolate reductase C677T mutation in splanchnic vein thrombosis.Semantic proximity Read ↗

Hyperhomocysteinaemia and factor V Leiden mutation are associated with Budd-Chiari syndrome.Semantic proximity Read ↗

Clinical significance of determining plasma homocysteine: case-control study on arterial and venous thrombotic patients.Semantic proximity Read ↗

Methylenetetrahydrofolate Reductase C677T Polymorphism, Venous Thrombosis, Cardiovascular Risk, and Other EffectsSemantic proximity Read ↗

C677T methylenetetrahydrofolate reductase gene polymorphism as a risk factor involved in venous thromboembolism: a population-based case-control study.Semantic proximity Read ↗

The Role of Vitamin B12 in Fasting Hyperhomocysteinemia and Its Interaction with the Homozygous C677T Mutation of the Methylenetetrahydrofolate Reductase (MTHFR) GeneSemantic proximity Read ↗

The 677T genotype of the common MTHFR thermolabile variant and fasting homocysteine in childhood venous thrombosis.Semantic proximity Read ↗

Methylenetetrahydrofolate reductase gene C677T mutation and plasma homocysteine level in Behçet's disease.Semantic proximity Read ↗

Polymorphisms C677T and A1298C of MTHFR Gene: Homocysteine Levels and Prothrombotic Biomarkers in Coronary and Pulmonary Thromboembolic Disease.Semantic proximity Read ↗

Influence of methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism, B vitamins and other factors on plasma homocysteine and risk of thromboembolic disease in Chinese.Semantic proximity Read ↗

Prevalence of methylenetetrahydrofolate reductase C677T and its association with arterial and venous thrombosis in the Chinese population.Semantic proximity Read ↗

Role of polymorphisms in factor V (FV Leiden), prothrombin, plasminogen activator inhibitor type-1 (PAI-1), methylenetetrahydrofolate reductase (MTHFR) and cystathionine β-synthase (CBS) genes as risk factors for thrombophilias.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.